In vitro study on the anticandidal activity of Melaleuca alternifolia (tea tree) essential oil combined with chitosan

Flavour and Fragrance Journal

Volumn 23, Issue 4, 2008, Pages 227-231

  Juliano, Claudia ^a   Demurtas, Carla ^a   Piu, Luisella ^a  

^a Dipartimento di Scienze del Farmaco   (Italy)

Author keywords

Antifungal activity; Candida albicans; Chitosan; Tea tree oil

Indexed keywords

CHITIN; CHITOSAN; ESSENTIAL OILS; PH EFFECTS; STANDARDS; TESTING;

ALBICANS; CANDIDA; CANDIDA ALBICANS; IN VITRO STUDIES; IN-VITRO; LIQUID MEDIUMS; MELALEUCA ALTERNIFOLIA; PH-DEPENDENT; SYNERGISTIC ACTION; TEA TREE OIL; YEAST CELLS;

AMINES;

CHITOSAN; TEA TREE OIL;

ACIDITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ANTAGONISM; GROWTH INHIBITION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; YEAST CELL;

CANDIDA; CANDIDA ALBICANS; MELALEUCA ALTERNIFOLIA;

EID: 48249140675     PISSN: 08825734     EISSN: 10991026     Source Type: Journal    
DOI: 10.1002/ffj.1871     Document Type: Article

References (38)

1. Altman PM. Aust. J. Pharm. 1988; 69: 276-278.
2. Brophy JJ, Davies NW, Southwell IA et al. J. Agric. Food Chem. 1989; 37: 1330-1335.
3. International Organization for Standardization. ISO 4730. ISO: Geneva, 1996.
4. Anonymous. European Pharmacopoeia, 5th edn. Council of Europe: Strasbourg, 2004; 2534-2535.
5. Humphrey EM. Med. J. Aust. 1930; 1: 417-418.
6. Buck DS, Nidorf DM, Addino JG. J. Fam. Pract. 1994; 38: 601-605.
7. Syed TA, Qureshi ZA, Ali SM et al. Trop. Med. Int. Health. 1999; 4: 284-287.
8. Satchel AC, Saurajen A, Bell C et al. Austral. J. Dermatol. 2002; 43: 175-178.
9. Mondello F, De Bernardis F, Girolamo A et al. J. Antimicrob. Chemother. 2003; 51: 1223-1229.
10. Hammer KA, Carson CF, Riley TV. Med. Mycol. 2000; 38: 355-362.
11. Hammer KA, Carson CF, Riley TV. J. Antimicrob. Chemother. 2002; 50: 195-199.
12. Vazquez JA, Zawawi AA. AIDS 2002; 12: 1033-1037.
13. Bagg J, Jackson MS, Sweeney MP et al. Oral Oncol. 2006; 42: 487-492.
14. Bagg J, Sweeney MP, Lewis MA et al. Palliat. Med. 2003; 17: 477-481.
15. Hausen BH. Dermatitis 2004; 15: 213-214.
16. Crawford GH, Sciacca JR, James WD. Dermatitis 2004; 15: 59-66.
17. Hammer KA, Carson CF, Riley TV et al. Food Chem. Toxicol. 2006; 44: 616-625.
18. Bergström MA, Luthman K, Nilsson JLG et al. Chem. Res. Toxicol. 2006; 19: 760-769.
19. Rabea EI, Badawy ME-T, Stevens CV et al. Biomacromolecules 2003; 4: 1457-1465.
20. Kim HJ, Lee HC, Oh JS et al. J. Biomater. Sci. Polym. Ed. 1999; 10: 543-556.
21. Felt O, Carrel A, Baehni P et al. J. Ocul. Pharmacol. Ther. 2000; 16: 261-270.
22. Zhilong S, Neoh KG, Kang ET et al. Biomaterials 2006; 27: 2440-2449.
23. Şenel S, Kaş S, Yousefi-Rad A et al. Int. J. Pharm. 2000; 193: 197-203.
24. Cuero RG, Osuji G, Washington A. Biotechnol. Lett. 1991; 13: 441-444.
25. Chen CS, Liau WY, Tsai GJ. J. Food Prot. 1998; 61: 1124-1128.
26. Park P-J, Je J-Y, Kim S-K. Carbohydr. Polym. 2004; 55: 17-22.
27. Xing R, Liu S, Zhanyong G et al. Bioorg. Med. Chem. 2005; 13: 1573-1577.
28. McGinnis MR, Rinaldi MG. In Antibiotics in Laboratory Medicine, 2nd edn, Lorian V (ed.). Williams and Wilkins: Baltimore, MD, 1986; 223-281.
29. Juliano C, Mattana A, Usai M. J. Essent. Oil Res. 2000; 12: 516-522.
30. King TC, Schlessinger D, Krogstad DJ. Rev. Infect. Dis. 1981; 3: 627-633.
31. Hammer KA, Carson CF, Riley TV. J. Antimicrob. Chemother. 1998; 42: 591-595.
32. Roller S, Covill N. Int. J. Food Microbiol. 1999; 47: 67-77.
33. Devlieghere F, Vermeulen A, Debevere J. Food Microbiol. 2004; 21: 703-714.
34. Kamil JYVA, Jeon Y-J, Shahidi F. Food Chem. 2002; 79: 69-77.
35. Georgantelis D, Ambrosiadis I., Katikov P et al. Meat Sci. 2007; 76:172-181.
36. Ueno H, Mori T, Fujinaga T. Adv. Drug Deliv. Rev. 2001; 52: 105-115.
37. Barembaum S, Virga C, Bojanich A et al. Med. Oral. 2003; 8: 188-196.
38. Aksungur P, Sungur A, Ünal S et al. J. Control. Release. 2004; 98: 269-279.